Verisfield UK Ltd. Greek Branch   Report issue

For profit Phase 1
Founded: Athens Greece (2000)
Status: No NME R&D (2000)

Organization Overview

First Clinical Trial
2014
NCT02146209
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (2)

metronidazole (flagyl) (2 trials)

rosuvastatin (crestor) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bacterial Infections (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 3
  • # of Trial APIs: 2